South Africa Biopharmaceuticals Market: By Product Type, By Application, and Country  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

South Africa Biopharmaceuticals Market: By Product Type (Monoclonal Antibodies, Interferons, Insulin, Growth, and Coagulation Factors, Erythropoietin, Vaccines, Hormones, Others,), By Application (Oncology, Blood Disorders, Metabolic Diseases, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases,Immunology,Others), and Country  

checked icon arrow_drop_down
checked icon Single User License $3100 $2480
checked icon Multiple User License $4600 $3680
checked icon Corporate User License $6900 $5520

1. Executive Summary
2. South Africa Biopharmaceuticals Market Introduction
2.1. South Africa Biopharmaceuticals Market Taxonomy
2.2. South Africa Biopharmaceuticals Market Definitions
2.2.1. Product
2.2.2. Application
3. South Africa Biopharmaceuticals Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. South Africa Biopharmaceuticals Market Dynamic Factors - Impact Analysis
3.6. South Africa Biopharmaceuticals Market Competition Landscape
4. South Africa Biopharmaceuticals Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. South Africa Biopharmaceuticals Market, By Product, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.1. Monoclonal Antibodies
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Interferons
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Insulin
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Growth and Coagulation Factors
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Erythropoietin
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Vaccines
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Hormones
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Others
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
6. South Africa Biopharmaceuticals Market Forecast, By Application, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.1. Oncology
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Blood Disorders
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Metabolic Diseases
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Infectious Diseases
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Cardiovascular Diseases
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Neurological Diseases
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Immunology
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Others
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
7. Competition Landscape 
7.1. Strategic Dashboard of Top Market Players
7.2. Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
7.2.1. Abbott Laboratories
7.2.2. Amgen, Inc.
7.2.3. Biogen, Inc.
7.2.4. Eli Lilly and Company
7.2.5. F. Hoffmann-La Roche, Ltd.
7.2.6. Johnson & Johnson
7.2.7. Merck & Co., Inc.
7.2.8. Novo Nordisk A/S
7.2.9. Pfizer, Inc.
7.2.10. Sanofi
8. Research Methodology
9. Key Assumptions and Acronyms
 

 

South Africa Biopharmaceuticals Market Segmentation Analysis

Report Benchmarks

Details

By Product Type

  • Monoclonal Antibodies
  • Interferons
  • Insulin
  • Growth and Coagulation Factors
  • Erythropoietin
  • Vaccines
  • Hormones
  • Others

By Application

  • Oncology
  • Blood Disorders
  • Metabolic Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Neurological Diseases
  • Immunology
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

2023 is the base year and 2030 is the forecast year.

The South Africa biopharmaceuticals market key players in the Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eli Lilly and Company, Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc, Novo Nordisk A/S, Pfizer, Inc., Sanofi

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Key Market Players

  • Abbott Laboratories
  • Amgen, Inc.
  • Biogen, Inc.
  • Eli Lilly and Company
  • Hoffmann-La Roche, Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Sanofi

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market